Natixis Advisors, L.P.
- SEC CIK
- 0001018331
- Latest filing
- Aug 14, 2026
MRNA holding history
Moderna, Inc. in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRNA overviewAll 13F holders of MRNAFull Q2 2026 holdings
- Shares (Q2 2026)
- 28,886
- Value
- $2.02M
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 28,886 | $2.02M | <0.1% | +15,396+114.1% | Added | Holders |
| Q1 2026 | 13,490 | $685.0K | <0.1% | +13,490 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −17,761−100.0% | Sold out | Holders |
| Q1 2025 | 17,761 | $504.0K | <0.1% | +7,356+70.7% | Added | Holders |
| Q4 2024 | 10,405 | $433.0K | <0.1% | −1,169−10.1% | Reduced | Holders |
| Q3 2024 | 11,574 | $773.0K | <0.1% | −58,936−83.6% | Reduced | Holders |
| Q2 2024 | 70,510 | $8.37M | <0.1% | +40,021+131.3% | Added | Holders |
| Q1 2024 | 30,489 | $3.25M | <0.1% | +5,877+23.9% | Added | Holders |
| Q4 2023 | 24,612 | $2.45M | <0.1% | +4,688+23.5% | Added | Holders |
| Q3 2023 | 19,924 | $2.06M | <0.1% | +3,310+19.9% | Added | Holders |
| Q2 2023 | 16,614 | $2.02M | <0.1% | −12,709−43.3% | Reduced | Holders |
| Q1 2023 | 29,323 | $4.50M | <0.1% | +573+2.0% | Added | Holders |
| Q4 2022 | 28,750 | $5.16M | <0.1% | +3,313+13.0% | Added | Holders |
| Q3 2022 | 25,437 | $3.01M | <0.1% | +13,586+114.6% | Added | Holders |
| Q2 2022 | 11,851 | $1.69M | <0.1% | −1,586−11.8% | Reduced | Holders |
| Q1 2022 | 13,437 | $2.31M | <0.1% | +3,178+31.0% | Added | Holders |
| Q4 2021 | 10,259 | $2.61M | <0.1% | −67,297−86.8% | Reduced | Holders |
| Q3 2021 | 77,556 | $29.8M | 0.1% | −145,991−65.3% | Reduced | Holders |
| Q2 2021 | 223,547 | $52.5M | 0.2% | +223,547 | New | Holders |